| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 85.30B | 80.92B | 67.56B | 61.00B | 49.27B | 44.79B |
| Gross Profit | 33.31B | 31.46B | 27.13B | 24.43B | 16.81B | 13.69B |
| EBITDA | 17.59B | 16.73B | 14.20B | 12.42B | 6.25B | 4.58B |
| Net Income | 10.91B | 10.33B | 8.79B | 9.20B | 2.98B | 1.97B |
Balance Sheet | ||||||
| Total Assets | 90.05B | 95.46B | 91.41B | 82.10B | 69.01B | 58.43B |
| Cash, Cash Equivalents and Short-Term Investments | 21.91B | 28.48B | 27.21B | 27.18B | 26.32B | 19.60B |
| Total Debt | 8.73B | 8.74B | 8.76B | 8.79B | 10.20B | 10.91B |
| Total Liabilities | 43.77B | 48.14B | 52.67B | 49.09B | 44.39B | 36.58B |
| Stockholders Equity | 46.28B | 47.32B | 38.73B | 33.01B | 24.61B | 21.85B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.07B | 3.89B | 3.38B | 7.89B | 7.54B |
| Operating Cash Flow | 0.00 | 6.99B | 5.99B | 4.57B | 8.30B | 7.67B |
| Investing Cash Flow | 0.00 | -3.22B | -2.31B | -1.38B | -507.00M | -258.00M |
| Financing Cash Flow | 0.00 | -2.67B | -3.75B | -2.44B | -1.21B | -553.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥13.71T | 30.90 | 12.80% | 0.78% | 7.09% | 7.51% | |
78 Outperform | ¥290.35B | 8.42 | ― | 2.04% | -0.69% | -29.88% | |
77 Outperform | ¥292.57B | 17.58 | ― | 1.49% | 18.20% | 28.13% | |
74 Outperform | ¥549.48B | 44.29 | 4.03% | 2.25% | 3.97% | -41.76% | |
62 Neutral | ¥425.86B | 19.19 | 5.63% | 2.35% | -9.06% | -35.95% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | ¥863.10B | 36.79 | 2.99% | 2.62% | 3.51% | ― |